These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19357389)

  • 21. Racial differences in prostate cancer treatment outcomes: a systematic review.
    Peters N; Armstrong K
    Cancer Nurs; 2005; 28(2):108-18. PubMed ID: 15815180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
    Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
    Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
    Nyame YA; Holt SK; Etzioni RD; Gore JL
    Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States).
    Rogers SO; Ray WA; Smalley WE
    Cancer Causes Control; 2004 Mar; 15(2):193-9. PubMed ID: 15017132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
    Klabunde CN; Potosky AL; Harlan LC; Kramer BS
    Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Black-white differences in survival from late-stage prostate cancer.
    Polednak AP
    Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of race on survival in men with metastatic hormone-refractory prostate cancer.
    Halabi S; Small EJ; Vogelzang NJ; Barrier RC; George SL; Gilligan TD
    Urology; 2004 Aug; 64(2):212-7. PubMed ID: 15302462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.
    Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL
    J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial disparities in colon cancer survival: a matched cohort study.
    Silber JH; Rosenbaum PR; Ross RN; Niknam BA; Ludwig JM; Wang W; Clark AS; Fox KR; Wang M; Even-Shoshan O; Giantonio BJ
    Ann Intern Med; 2014 Dec; 161(12):845-54. PubMed ID: 25506853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
    Shavers VL; Brown ML; Potosky AL; Klabunde CN; Davis WW; Moul JW; Fahey A
    J Gen Intern Med; 2004 Feb; 19(2):146-55. PubMed ID: 15009794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in socioeconomic status and survival among white and black men with prostate cancer.
    Robbins AS; Whittemore AS; Thom DH
    Am J Epidemiol; 2000 Feb; 151(4):409-16. PubMed ID: 10695600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential association of race with treatment and outcomes in Medicare patients undergoing diverticulitis surgery.
    Schneider EB; Haider A; Sheer AJ; Hambridge HL; Chang DC; Segal JB; Wu AW; Lidor AO
    Arch Surg; 2011 Nov; 146(11):1272-6. PubMed ID: 22106319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients.
    Holmes JA; Carpenter WR; Wu Y; Hendrix LH; Peacock S; Massing M; Schenck AP; Meyer AM; Diao K; Wheeler SB; Godley PA; Stitzenberg KB; Chen RC
    J Urol; 2012 Mar; 187(3):883-8. PubMed ID: 22248516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity and survival disparities among black and white patients with breast cancer.
    Tammemagi CM; Nerenz D; Neslund-Dudas C; Feldkamp C; Nathanson D
    JAMA; 2005 Oct; 294(14):1765-72. PubMed ID: 16219879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia: An Analysis of Within- and Between-Hospital Variation.
    Downing NS; Wang C; Gupta A; Wang Y; Nuti SV; Ross JS; Bernheim SM; Lin Z; Normand ST; Krumholz HM
    JAMA Netw Open; 2018 Sep; 1(5):e182044. PubMed ID: 30646146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
    Singal V; Singal AK; Kuo YF
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy.
    Lee DJ; Ritch C; Desai M; Benson MC; McKiernan JM
    BJU Int; 2011 Jun; 107(11):1741-7. PubMed ID: 20942835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.
    Hayn MH; Orom H; Shavers VL; Sanda MG; Glasgow M; Mohler JL; Underwood W
    Cancer; 2011 Oct; 117(20):4651-8. PubMed ID: 21456009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.